Hou LK - Search Results

1

[Pulmonary granular cell tumors: a clinicopathological analysis of five cases].

Liu HF, Huang Y, Wu CY, Li Y, Wang YC, Zhang LP, Hou LK, Xie HK. Liu HF, et al. Among authors: hou lk. Zhonghua Bing Li Xue Za Zhi. 2023 Feb 8;52(2):136-141. doi: 10.3760/cma.j.cn112151-20220628-00556. Zhonghua Bing Li Xue Za Zhi. 2023. PMID: 36748133 Chinese.

2

Effect of hyperlipidemia on the expression of circadian genes in apolipoprotein E knock-out atherosclerotic mice.

Hou L, Lu C, Huang Y, Chen S, Hua L, Qian R. Hou L, et al. Lipids Health Dis. 2009 Dec 30;8:60. doi: 10.1186/1476-511X-8-60. Lipids Health Dis. 2009. PMID: 20040117 Free PMC article.

3

Wedge resection for localized infectious lesions: high margin/lesion ratio guaranteed operational safety.

Sun Y, Hou L, Xie H, Zheng H, Jiang G, Gao W, Chen C. Sun Y, et al. J Thorac Dis. 2014 Sep;6(9):1173-9. doi: 10.3978/j.issn.2072-1439.2014.08.30. J Thorac Dis. 2014. PMID: 25276357 Free PMC article.

4

High feasibility of liquid-based cytological samples for detection of EGFR mutations in Chinese patients with NSCLC.

Wu CY, Hou LK, Ren SX, Su B, Chen G. Wu CY, et al. Among authors: hou lk. Asian Pac J Cancer Prev. 2014;15(18):7885-9. doi: 10.7314/apjcp.2014.15.18.7885. Asian Pac J Cancer Prev. 2014. PMID: 25292082 Free article.

5

Long non-coding RNA UCA1 is a predictive biomarker of cancer.

Hong HH, Hou LK, Pan X, Wu CY, Huang H, Li B, Nie W. Hong HH, et al. Among authors: hou lk. Oncotarget. 2016 Jul 12;7(28):44442-44447. doi: 10.18632/oncotarget.10142. Oncotarget. 2016. PMID: 27329842 Free PMC article.

6

[Clinicopathologic features and epidermal growth factor receptor gene mutation of primary pulmonary mucoepidermoid carcinoma].

Huang Y, Wu CY, Wu W, Hou LK, Zhang LP. Huang Y, et al. Among authors: hou lk. Zhonghua Bing Li Xue Za Zhi. 2016 Sep 8;45(9):612-6. doi: 10.3760/cma.j.issn.0529-5807.2016.09.005. Zhonghua Bing Li Xue Za Zhi. 2016. PMID: 27646889 Chinese.

7

Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy.

Hou LK, Ma YS, Han Y, Lu GX, Luo P, Chang ZY, Xie RT, Yang HQ, Chai L, Cai MX, Wu TM, Yu F, Qin SS, Lv ZW, Wu CY, Fu D. Hou LK, et al. PLoS One. 2017 Jan 31;12(1):e0170431. doi: 10.1371/journal.pone.0170431. eCollection 2017. PLoS One. 2017. PMID: 28141816 Free PMC article.

8

[Clinicopathologic features and genetic profile of the redefined large cell lung carcinoma].

Hou LK, Zhang LP, Zhang W, Huang Y, Wu W, Dong ZW, Wu CY. Hou LK, et al. Zhonghua Bing Li Xue Za Zhi. 2017 May 8;46(5):298-302. doi: 10.3760/cma.j.issn.0529-5807.2017.05.003. Zhonghua Bing Li Xue Za Zhi. 2017. PMID: 28468033 Chinese.

9

Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.

Yu F, Liu JB, Wu ZJ, Xie WT, Zhong XJ, Hou LK, Wu W, Lu HM, Jiang XH, Jiang JJ, Cao ZY, Cong GJ, Shi MX, Jia CY, Lu GX, Song YC, Chai L, Lv ZW, Wu CY, Ma YS, Fu D. Yu F, et al. Among authors: hou lk. Cancer Lett. 2018 Jul 28;427:74-84. doi: 10.1016/j.canlet.2018.04.022. Epub 2018 Apr 24. Cancer Lett. 2018. PMID: 29702194

10

miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1.

Ma YS, Yu F, Zhong XM, Lu GX, Cong XL, Xue SB, Xie WT, Hou LK, Pang LJ, Wu W, Zhang W, Cong LL, Liu T, Long HD, Sun R, Sun HY, Lv ZW, Wu CY, Fu D. Ma YS, et al. Among authors: hou lk. Mol Ther. 2018 Dec 5;26(12):2751-2765. doi: 10.1016/j.ymthe.2018.09.006. Epub 2018 Sep 13. Mol Ther. 2018. PMID: 30301667 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters